Has David Stewart received payments from drug or device companies?

Yes. Drug and device makers reported $2,858 in general payments to David Stewart across 127 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Stewart did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Stewart come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Stewart

Family · Georgetown, DENPI 1679964688

Payments from drug & device makers

$2,858in general payments, 2019–2025

Across 127 payments — averaging $22.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$647
Otsuka America Pharmaceutical, Inc.$570
Johnson & Johnson$225
Lundbeck LLC$205
Tris Pharma Inc$176
Alkermes, Inc.$173
plus $863 from 13 others

What the payments were for

Food & beverage$2,83199%
Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	35	$647
Otsuka America Pharmaceutical, Inc.	16	$570
Johnson & Johnson	5	$225
Lundbeck LLC	11	$205
Tris Pharma Inc	10	$176
Alkermes, Inc.	8	$173
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	9	$160
Takeda Pharmaceuticals U.S.A., Inc.	7	$140
Corium, LLC	6	$139
Neurocrine Biosciences, Inc.	6	$117
Indivior Inc.	3	$81
Vanda Pharmaceuticals Inc.	3	$60
Sunovion Pharmaceuticals Inc.	2	$40
E.r. Squibb & Sons, L.L.C.	1	$27
Almatica Pharma LLC	1	$24
Teva Pharmaceuticals USA, Inc.	1	$24
Supernus Pharmaceuticals, Inc.	1	$19
Axsome Therapeutics, Inc.	1	$17
Avanir Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,858 in reported general payments places this provider in the 85th percentile of 523 family providers in Delaware.

See all family providers in Delaware →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RexultiBrexpiprazole	28	$47,626
Duloxetine Hcl	26	$715
Bupropion XlBupropion Hcl	11	$452
Lurasidone Hcl	11	$183
Fluoxetine Hcl	14	$124
Gabapentin	11	$68
Sertraline Hcl	16	$52
Trazodone Hcl	11	$21

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti	$570	$47,62628 claims
Almatica Pharma LLCSertraline Hcl	$24	$5216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 523 family providers in Delaware.

Other family in Georgetown

Abby AllenGeorgetown$43K
Jennifer CallardGeorgetown$13K
Candice RobertsGeorgetown$8K
Brandi GreggeMiddletown$110K
Tracy EstesWilmington$59K
Kathy GallagherNewark$53K
Jodie DelesioNewark$50K
Taylor HodgesLewes$33K
Jodi KahanWilmington$21K
Valerie HarrisonBridgeville$15K

See the full list for Delaware →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →